Clinical Trial Update: A Study of Withdrawal Effects With Dapoxetine in the Treatment of Premature Ejaculation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update focusing on withdrawal effects observed with dapoxetine for treating premature ejaculation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Ejaculation

Drugs mentioned

• Dapoxetine (dapoxetine)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Sexual Dysfunction, Ejaculation | Phase 3 | Status: COMPLETED